BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 17, 2000
View Archived Issues
Columbia concluding phase III study on anti-AIDS spermicide
Read More
Private companies cooperate with U.N. on HIV/AIDS treatment access in developing countries
Read More
DeveloGen and HepaVec to merge
Read More
Orphan drug status granted for Merrem I.V. as cystic fibrosis treatment
Read More
Avax begins phase I/II study of L-Vax for treatment of AML
Read More
Uniprost to be marketed by Ferrer in Europe and Latin America
Read More
Amylin and Alkermes establish agreement for new formulation of AC-2993
Read More
Ligand reports data from two trials of Targretin gel formulation in CTCL
Read More
Researchers at Ortho-McNeil claim new series of NPY Y5 receptor ligands and use thereof
Read More
Primate-specific genotype of hepatitis B suggests new theory for virus pandemic
Read More
Inhaled interleukin-2 shows promise as a treatment for lung metastases of malignant melanoma
Read More
Glaxo Wellcome reveals recent findings in its thrombin inhibitor program
Read More
ADIR describes preparation and use of new cyclic melatonin receptor ligands
Read More
Nonpeptide GnRH receptor modulators with improved pharmaceutical properties
Read More
Joint research at Japanese labs leads to design of high-affinity MDR ligands
Read More
New series of ECE inhibitors in early development by Sumitomo
Read More
Conjugates for diagnosis and treatment of tumors prepared at Schering
Read More
Japanese patent covers Kanebo's new Na+/H+ exchange inhibitors
Read More
Bronchodilating PDE4 inhibitors synthesized and tested by Dainippon
Read More
Human MAbs targeting PTHrP useful for bone and calcium metabolism disorders
Read More
Drug may provide the basis for a new class of neuropsychiatric medications
Read More
Two potent and selective iNOS inhibitors discovered by Glaxo Wellcome
Read More
Eryloside F: a new thrombin receptor antagonist produced by a marine sponge
Read More
Company Profile: Salpep Biotechnology
Read More
Transplant 2000 news: JAK3 inhibitor shows promise for islet transplantation
Read More
Company Profile: Axxima Pharmaceuticals
Read More
Significant CD3 depletion with minimal cytokine release in patients receiving PDL's HuM291
Read More
POH presented at Transplant 2000 as representative of a new class of immunosuppressants
Read More